Linked Life Data

11123486

Source:http://linkedlifedata.com/resource/pubmed/id/11123486

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-1-4
pubmed:abstractText
A variety of detoxification methods have been utilized for the treatment of opiate withdrawal syndrome, of which alpha-adrenergic agonists have attracted considerable attention over the last two decades. However, accumulating evidence in rats shows the efficacy of the GABAB receptor agonist, baclofen, in reducing alcohol intake and self-administration of cocaine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0269-4727
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
347-53
pubmed:dateRevised
2008-5-28
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal.
pubmed:affiliation
Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Avenue, Tehran, Iran. s.akhond@neda.net
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial